The Patent Finder

Maintenance fees coming due

Novartis Pharma AG

8 maintenance fees come due in the 12 months from Nov 16, 2026, the next on Apr 30, 2027. Unpaid by Nov 1, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5 and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the six month grace period that follows.
PatentTitleHolderStatusFee dueLapses if unpaidExpiresConfidence
US 11,801,300Pharmaceutical Products and Stable Liquid Compositions of IL-17 Antibodies
In force
Fee due Apr 30, 2027
Lapses if unpaid Nov 1, 2027
 · High confidence
Novartis Pharma AGIn forceApr 30, 2027Nov 1, 2027High confidence
US 11,807,855Selection Vectors and Methods of Selecting Eukaryotic Host Cells
In force
Fee due May 7, 2027
Lapses if unpaid Nov 8, 2027
 · High confidence
Novartis Pharma AGIn forceMay 7, 2027Nov 8, 2027High confidence
US 10,501,525Methods for Purification of Antibodies Using Aliphatic Alcohols
In force
Fee due Jun 10, 2027
Lapses if unpaid Dec 10, 2027
 · High confidence
Novartis Pharma AGIn forceJun 10, 2027Dec 10, 2027High confidence
US 11,851,666Multi-Copy Gene Protein Expression System
In force
Fee due Jun 26, 2027
Lapses if unpaid Dec 27, 2027
 · High confidence
Novartis Pharma AGIn forceJun 26, 2027Dec 27, 2027High confidence
US 9,220,631Syringe
In force
Fee due Jun 29, 2027
Lapses if unpaid Dec 29, 2027
 · High confidence
Novartis Technology LLC, Novartis Pharmaceuticals Corporation and Novartis Pharma AGIn forceJun 29, 2027Dec 29, 2027High confidence
US 11,865,109Formulations of (S)-3-Amino-6-Methoxy-N-(3,3,3-Trifluoro-2-Hydroxy-2-Methylpropyl)-5-(TRIFLUOROMETHYL)PICOLINAMIDE
In force
Fee due Jul 9, 2027
Lapses if unpaid Jan 10, 2028
 · High confidence
Novartis AGIn forceJul 9, 2027Jan 10, 2028High confidence
US 10,583,190Methods of Treating Psoriasis Using IL-17 Antibodies
In force
Fee due Sep 10, 2027
Lapses if unpaid Mar 10, 2028
 · Medium confidence
Novartis Pharma AGIn forceSep 10, 2027Mar 10, 2028Medium confidence
US 9,295,668Use of an Aromatase Inhibitor for the Treatment of Hypogonadism and Related Diseases
In force
Fee due Sep 29, 2027
Lapses if unpaid Mar 29, 2028
 · High confidence
Mereo Biopharma 2 LimitedIn forceSep 29, 2027Mar 29, 2028High confidence
8 of 8 patents shown. Soonest fee due date first, then patent number.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited